Ten services studied had high rates, between 9 % and almost 16 %, whereas six facilities reported no misuse at all for days gone by year. The commission said prison management must show leadership in stopping such abuse. Inmates in jails reported fewer cases of rape than in prisons. Inmates who were short, young, gay or feminine were much more likely to end up being victimized than other inmates. To fight the nagging problem, the commission says prison authorities should adopt more internal monitoring and external oversight. They also say prison officials need to improve investigation of statements of sexual assault and rape, because currently many victims cannot safely and easily come ahead.To aid clinical studies of pralatrexate , Allos Therapeutics, Inc.) in the treating select hematologic malignancies and solid tumors. Pralatrexate was lately authorized by the FDA to take care of individuals with refractory or relapsed peripheral T-cell lymphoma, a type of non-Hodgkin’s lymphoma that’s relatively uncommon, but aggressive particularly. Clinical trials backed by this grant will concentrate on evaluating innovative single agent and combination studies of pralatrexate in Burkitt’s lymphoma, multiple myeloma, specific indolent lymphomas, ovarian cancers, head and neck cancer, prostate cancers, gastroesophageal cancers, and colorectal tumor.